Ignite Creation Date:
2024-05-06 @ 12:25 AM
Last Modification Date:
2024-10-26 @ 10:50 AM
Study NCT ID:
NCT01574872
Status:
WITHDRAWN
Last Update Posted:
2014-11-18
First Post:
2012-04-06
Brief Title:
Efficacy of Aerosal in the Treatment of Inverse Psoriasis and Sebopsoriasis
Sponsor:
Tecno Sun SRL
Organization:
Tecno Sun SRL
Study Overview
Official Title:
Double-blind Randomized Placebo Controlled Study Evaluating the Efficacy of Aerosal in the Treatment of Inverse Psoriasis and Sebopsoriasis
Status:
WITHDRAWN
Status Verified Date:
2014-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Changes in the sponsorship design and locations of the study
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the efficacy of Aerosal compared to placebo in the prognosis of inverse psoriasis or sebopsoriasis present for at least one year
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None